41 – 50 of 137
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Predicting beneficial effects of atomoxetine and citalopram on response inhibition in Parkinson's disease with clinical and neuroimaging measures
(
- Contribution to journal › Article
-
Mark
Different decision deficits impair response inhibition in progressive supranuclear palsy and Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Gray and white matter imaging : A biomarker for cognitive impairment in early Parkinson's disease?
(
- Contribution to journal › Article
-
Mark
The restorative effect of PDGF-BB in Parkinson disease therapy
2016) FENS Forum 2016(
- Contribution to conference › Abstract
-
Mark
Health and social service access among family caregivers of people with Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Extensive graft-derived dopaminergic innervation is maintained 24 years after transplantation in the degenerating parkinsonian brain.
2016) In Proceedings of the National Academy of Sciences of the United States of America 113(23). p.6544-6549(
- Contribution to journal › Article
-
Mark
Life satisfaction in Parkinson's disease - associated factors
2016) The 20th International Congress of Parkinson's Disease and Movement Disorders(
- Contribution to conference › Abstract
-
Mark
Heterozygous PINK1 p.G411S mutation increases risk for Parkinson's disease (PD)
2016) 20th International Congress of Parkinson's Disease and Movement Disorders In Movement Disorders 31(Suppl. S2). p.282-282(
- Contribution to journal › Published meeting abstract
- 2015
-
Mark
Anticholinergic Load : Is there a Cognitive Cost in Early Parkinson's Disease?
(
- Contribution to journal › Article
-
Mark
Tracking Parkinson's : Study Design and Baseline Patient Data
(
- Contribution to journal › Article